Insider filing · ABT
Sally E. Blount
Director
profile →
Abbott Laboratories
ABT · Healthcare · 65 filings in 24 months
ticker →
Sally E. Blount sold $337K of Abbott Laboratories (ABT)
Executed Apr 30 2025, disclosed May 2 2025, 2 days later.
Value, as filed
$337K
2,600 sh × $129.66
Executed
Apr 30 2025
the trade date, as filed
Disclosed
May 2 2025
2 days after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
SBSally E. Blount (Director) filed 1 Form 4 report in the past 24 months (0 purchases, 1 sale), most often in Abbott Laboratories (ABT). The largest single filing was $337K of ABT (2,600 sh × $129.66, as filed), executed Apr 30 2025.
The name
ABTHealthcare · Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→